Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months (Q44302205)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months |
scientific article |
Statements
1 reference
Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months (English)
1 reference
Rafael Blesa
1 reference
Michael Davidson
1 reference
Alexander Kurz
1 reference
William Reichman
1 reference
Bart van Baelen
1 reference
Susanne Schwalen
1 reference
1 January 2003
1 reference
1 reference
Identifiers
1 reference